Company news
EVE Health Group Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Meluka Honey Appoints OpenDNA for Chinese Market Entry
March 11, 2019
EVE to Acquire Remaining 50% of Meluka Health
February 24, 2019
Response to ASX Appendix 4C Query
February 19, 2019
Meluka Honey Secures Distribution for NSW & ACT
November 13, 2018
Meluka Honey Combines Anti-Microbial & Anti-Oxidant Activity
November 7, 2018
Appendix 4E and Full Year Statutory Accounts
August 31, 2018
Completion of THC Agreements
July 24, 2018
Omni Innovation - Update by Eagle Health on Chinese Market
July 15, 2018
Update on THC Agreements
July 2, 2018
EVE to Acquire Leading Aust Organic Tea Tree Oil Producer
June 20, 2018
First Quarter China Sales Progress
April 26, 2018
Half Yearly Report and Accounts
February 26, 2018
Meluka Consumer Products Launch at US Natural Products Expo
February 22, 2018
Oversubscribed Placement & Rights Issue to Raise up to $6.3m
January 30, 2018
Eagle Begins Shipment of Omni Innovations Diabetes Product
December 7, 2017
Meluka Health to Develop Honey Water for Chinese Market
December 6, 2017
Eve Completes 50% Investment in Meluka Health
December 5, 2017
Response to ASX Price & Volume Query
November 30, 2017
NSW Grant for Honey Research Successful
November 26, 2017
Medic Honey Produces a Hemp Seed Honey
November 21, 2017
Supply Agmt with Large Producer of Australian Organic Honey
November 5, 2017
Eagle Commences Production of Omnis Pre-Meal Diabetes Shake
October 30, 2017
Appendix 4C - Quarterly
October 20, 2017
$1.2m Capital Raising
October 5, 2017
Revised Medical Honey Investment Structure
August 27, 2017
Omni Innovation Enters Chinese Distribution Agreement
August 16, 2017
Accelerating Portfolio Progress
June 25, 2017
Southern Cross University Collaboration with Medic Honey
May 29, 2017
Omni Innovation - US Patent Notice of Allowance Received
February 28, 2017
Sales Results Exceed Expectations for Faulding GlucoControl
January 24, 2017
$1.6m Placement for Omni Innovation Investment
December 23, 2016
Notification of Rights Issue Shortfall
December 9, 2016
Omni Innovation Market Update
December 1, 2016
Omni Innovation secures UK Distribution Deal
November 20, 2016
Placement to Chinese Pharmaceutical and Investment Group
November 9, 2016
New Study- GlucoControl Improves Long-Term Glycaemic Control
September 20, 2016
Omniblend Innovation Enters into US Representation Deal
August 23, 2016
GlucoControl Momentum
July 4, 2016
GlucoControl Pre-Meal Drink Launched
May 5, 2016
Extension of Omniblend Innovation Tranche 2 Settlement
March 31, 2016
Non-Renounceable Issue
March 30, 2016
GlucoControl Product Manufacturing Commences
February 25, 2016
Fully Underwritten Rights Issue
February 18, 2016
EVE Investments makes first medical technology investment
February 11, 2016
EVE: Company Update
February 10, 2016
Energy Ventures: 13 November 2015 - Net Tangible Asset Backing
November 12, 2015
Energy Ventures: 19 October 2015 - Prospectus
October 18, 2015
Energy Ventures: 19 October 2015 - Notice of Annual General Meeting/Proxy Form
October 18, 2015
Energy Ventures: 19 October 2015 - Appendix 4G and Corporate Governance Statement
October 18, 2015
Energy Ventures: 19 October 2015 - Annual Report to Shareholders
October 18, 2015
Decks
The 5 newest of 34 decks. Every deck is listed under its year.
- Investor Presentation (November 2026)
Investor deck · 18 slides · Nov 12, 2026
- Coffee Microcaps Conference (September 2026)
Conference · 18 slides · Sep 22, 2026
- Investor Presentation (March 2026)
Investor deck · 15 slides · Mar 26, 2026
- Investor Presentation (November 2025)
Investor deck · 14 slides · Nov 20, 2025
- Spark Plus Australian Equities Day 2025
Conference · 13 slides · Oct 3, 2025